Back to Search
Start Over
Efficacy and Safety of Combined Vitrectomy with Intravitreal Dexamethasone Implant for Advanced Stage Epiretinal Membrane
- Source :
- Drug Design, Development and Therapy, Vol Volume 13, Pp 4107-4114 (2019), Drug Design, Development and Therapy
- Publication Year :
- 2019
- Publisher :
- Dove Medical Press, 2019.
-
Abstract
- Claudio Iovino,1 Giuseppe Giannaccare,2 Marco Pellegrini,2 Federico Bernabei,2 Mirco Braghiroli,1 Tomaso Caporossi,3 Enrico Peiretti1,4 1Department of Surgical Sciences, Eye Clinic, University of Cagliari, Cagliari, Italy; 2Ophthalmology Unit, S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy; 3Department of Ophthalmology, Ospedale Careggi, Firenze, Italy; 4Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, Cagliari, ItalyCorrespondence: Enrico PeirettiEye Clinic, University of Cagliari, Via Ospedale 48, Cagliari 09124, ItalyTel|Fax +390706092319Email enripei@hotmail.comPurpose: To evaluate the efficacy and safety of combined 25-gauge (G) pars plana vitrectomy (PPV) with intravitreal dexamethasone implant (DXI) for the treatment of advanced stage epiretinal membrane (ERM).Methods: Forty consecutive pseudophakic eyes with idiopathic stage 3–4 ERM and intraretinal cysts were randomly assigned to two treatment groups. Twenty eyes underwent combined 25-G PPV, ERM peeling and slow-release DXI (DEX group), whereas 20 eyes underwent standard 25-G PPV with ERM peeling only (control group). Differences in postoperative best-corrected visual acuity (BCVA), intraocular pressure (IOP), central macular thickness (CMT) were evaluated.Results: In all patients, BCVA significantly increased at 1, 3 and 6 months after surgery compared to baseline (all p < 0.05), but at 3 and 6 months, the visual gain was higher in the DEX group (respectively, p = 0.036, p = 0.006). CMT was significantly lower in DEX group compared to control group at 3 and 6 months after surgery (respectively, p = 0.042, p = 0.003). There was no statistically significant difference in IOP change over the course of the follow-up between groups (p > 0.05).Conclusion: Combined 25-G PPV with DXI is associated with better anatomical and functional outcomes in patients with advanced stage ERM.Keywords: epiretinal membrane, intravitreal dexamethasone, macular pucker, intraretinal cysts
- Subjects :
- Male
Pseudophakia
genetic structures
intraretinal cysts
Dexamethasone
NO
intravitreal dexamethasone
Vitrectomy
Humans
macular pucker
Prospective Studies
Original Research
Aged
Drug Design, Development and Therapy
Intravitreal Injection
lcsh:RM1-950
epiretinal membrane
eye diseases
epiretinal membrane, intravitreal dexamethasone, macular pucker, intraretinal cysts
Prospective Studie
lcsh:Therapeutics. Pharmacology
Intravitreal Injections
Intraretinal cyst
Female
sense organs
Human
Subjects
Details
- Language :
- English
- ISSN :
- 11778881
- Database :
- OpenAIRE
- Journal :
- Drug Design, Development and Therapy
- Accession number :
- edsair.pmid.dedup....9c5689475f333003dec6568b45b20c10